Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 278

1.

[Creation, implementation and objectives of CARADERM, a national network for rare skin carcinomas - Adnexal neoplasm part].

Seris A, Battistella M, Beylot-Barry M, Dalle S, Mortier L, Lebbé C, Blom A, Neidhart-Berard EM, Kramkimel N, Dupuy A, Zehou O, Dalac S, Jullie ML, Cribier B, Jouary T; Pour CARADERM, réseau de cancers rares dermatologiques (www.caraderm.org); le Groupe de cancérologie cutanée de la Société française de dermatologie.

Ann Dermatol Venereol. 2019 Sep 30. pii: S0151-9638(19)30287-X. doi: 10.1016/j.annder.2019.07.006. [Epub ahead of print] French.

PMID:
31582261
2.

Characteristics, Associated Diseases, and Management of Gram-negative Toe-web Infection: A French Experience.

Goiset A, Milpied B, Marti A, Marie J, Leroy-Colavolpe V, Pham-Ledard A, Chosidow O, Beylot-Barry M.

Acta Derm Venereol. 2019 Sep 10. doi: 10.2340/00015555-3315. [Epub ahead of print]

3.

Rituximab is an Effective Treatment in Patients with Pemphigus Vulgaris and Demonstrates a Steroid-Sparing Effect.

Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18482. [Epub ahead of print]

PMID:
31487383
4.

Users of Biologics in Clinical Practice: would they be eligible for Phase III Clinical Studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ.

Masson Regnault M, Castañeda-Sanabria J, Diep Tran MHT, Beylot-Barry M, Bachelez H, Beneton N, Chosidow O, Dupuy A, Joly P, Jullien D, Mahé E, Richard MA, Viguier M, Tubach F, Sbidian E, Paul C; et The PsoBioTeq Study Group.

J Eur Acad Dermatol Venereol. 2019 Aug 16. doi: 10.1111/jdv.15878. [Epub ahead of print]

PMID:
31419355
5.

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Preexisting Autoimmune Disease: A Nationwide Multicenter Cohort Study.

Tison A, Quéré G, Misery L, Funck-Brentano E, Danlos FX, Routier E, Robert C, Loriot Y, Lambotte O, Bonniaud B, Scalbert C, Maanaoui S, Lesimple T, Martinez S, Marcq M, Chouaid C, Dubos C, Brunet-Possenti F, Stavris C, Chiche L, Beneton N, Mansard S, Guisier F, Doubre H, Skowron F, Aubin F, Zehou O, Roge C, Lambert M, Pham-Ledard A, Beylot-Barry M, Veillon R, Kramkimel N, Giacchero D, Quatrebarbes J, Michel C, Auliac JB, Gonzales G, Decroisette C, Le Garff G, Carpiuc I, Vallerand H, Nowak E, Cornec D, Kostine M; Groupe de Cancérologie Cutanée (GCC), Groupe Français de Pneumo-Cancérologie (GFPC), Club Rhumatismes et Inflammations (CRI).

Arthritis Rheumatol. 2019 Aug 5. doi: 10.1002/art.41068. [Epub ahead of print]

PMID:
31379105
6.

Éditorial.

Viguier M, Aubin F, Bachelez H, Beylot-Barry M, Richard MA; Groupe de recherche sur le psoriasis de la Société française de dermatologie.

Ann Dermatol Venereol. 2019 Jun - Jul;146(6-7):423-425. doi: 10.1016/j.annder.2019.04.018. Epub 2019 Jun 20. French. No abstract available.

PMID:
31229352
7.

[Methotrexate].

Beylot-Barry M, Le Maitre M, Goujon C; Groupe de recherche sur le psoriasis de la Société française de dermatologie.

Ann Dermatol Venereol. 2019 Jun - Jul;146(6-7):459-465. doi: 10.1016/j.annder.2019.04.009. Epub 2019 Jun 14. French. No abstract available.

PMID:
31204126
8.

[Private-hospital network: Organisation of joint private-hospital follow-up].

Le Maître M, Beylot-Barry M; Groupe de recherche sur le psoriasis de la Société française de dermatologie.

Ann Dermatol Venereol. 2019 Jun - Jul;146(6-7):520-522. doi: 10.1016/j.annder.2019.04.002. Epub 2019 Jun 14. French. No abstract available.

PMID:
31204121
9.

Mutations of the B-cell receptor pathway confer chemoresistance in primary cutaneous diffuse large B-cell lymphoma leg-type.

Ducharme O, Beylot-Barry M, Pham-Ledard A, Bohers E, Viailly PJ, Bandres T, Faur N, Frison E, Vergier B, Jardin F, Merlio JP, Gros A.

J Invest Dermatol. 2019 May 28. pii: S0022-202X(19)31572-6. doi: 10.1016/j.jid.2019.05.008. [Epub ahead of print]

PMID:
31150604
10.

Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

Molloy K, Jonak C, Woei-A-Jin FJSH, Guenova E, Busschots AM, Bervoets A, Hauben E, Knobler R, Porkert S, Fassnacht C, Cowan R, Papadavid E, Beylot-Barry M, Berti E, Alberti Violetti S, Estrach T, Matin R, Akilov O, Vakeva L, Prince M, Bates A, Bayne M, Wachsmuch R, Wehkamp U, Marschalko M, Servitje O, Turner D, Weatherhead S, Wobser M, Sanches JA, McKay P, Klemke D, Peng C, Howles A, Yoo J, Evison F, Scarisbrick J.

Br J Dermatol. 2019 May 2. doi: 10.1111/bjd.18089. [Epub ahead of print]

PMID:
31049926
11.

Severe hypercalcemia complicating granulomatous slack skin disease: an exceptional case.

Bettuzzi T, Ram-Wolff C, Hau E, de Masson A, Vignon-Pennamen MD, Beylot-Barry M, Cormier C, Bagot M.

J Eur Acad Dermatol Venereol. 2019 Apr 26. doi: 10.1111/jdv.15646. [Epub ahead of print] No abstract available.

PMID:
31026372
12.

Psoriasis and male sexuality.

Dauendorffer JN, Ly S, Beylot-Barry M.

Ann Dermatol Venereol. 2019 Apr;146(4):273-278. doi: 10.1016/j.annder.2019.01.021. Epub 2019 Mar 28.

PMID:
30928124
13.

[The place of Androcur® in the treatment of diffuse female pattern hair loss].

Pham AD, Guillot B, Beylot-Barry M, Chosidow O, Reygagne P, Joly P.

Ann Dermatol Venereol. 2019 Apr;146(4):311-312. doi: 10.1016/j.annder.2019.02.008. Epub 2019 Mar 27. French. No abstract available.

PMID:
30926139
14.

Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort.

Tétu P, Allayous C, Oriano B, Dalle S, Mortier L, Leccia MT, Guillot B, Dalac S, Dutriaux C, Lacour JP, Saiag P, Brunet-Possenti F, De Quatrebarbes J, Stoebner PE, Legoupil D, Beylot-Barry M, Lesimple T, Aubin F, Dreno B, Mohamed S, Ballon A, Porcher R, Lebbe C.

Eur J Cancer. 2019 May;112:38-46. doi: 10.1016/j.ejca.2019.02.009. Epub 2019 Mar 22.

PMID:
30909072
15.

Pyoderma gangrenosum misdiagnosed as necrotising fasciitis or a real association between the two?

Cirotteau P, Heron-Mermin D, Dimicoli-Salazar S, Gérard E, Leroy H, Clément L, Beylot-Barry M.

J Eur Acad Dermatol Venereol. 2019 Aug;33(8):e305-e306. doi: 10.1111/jdv.15585. Epub 2019 Apr 3. No abstract available.

PMID:
30897232
16.

Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis.

Phan C, Beauchet A, Burztejn AC, Severino-Freire M, Barbarot S, Girard C, Lasek A, Reguiai Z, Hadj-Rabia S, Abasq C, Brenaut E, Droitcourt C, Perrussel M, Mallet S, Phan A, Lacour JP, Khemis A, Bourrat E, Chaby G, Deborde R, Plantin P, Maruani A, Piram M, Maccari F, Fougerousse AC, Kupfer-Bessaguet I, Balguérie X, Barthelemy H, Martin L, Quiles-Tsimaratos N, Mery-Brossard L, Pallure V, Lons-Danic D, Bouilly-Auvray D, Beylot-Barry M, Puzenat E, Aubin F, Mahé E; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique; Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie.

J Eur Acad Dermatol Venereol. 2019 Mar 18. doi: 10.1111/jdv.15579. [Epub ahead of print]

PMID:
30883928
17.

Extrafacial necrobiotic xanthogranuloma and monoclonal gammopathy: two cases.

Legrand A, Jullie ML, Ly S, Beylot-Barry M, Viallard JF, Calonje J, Bureau-Lenoir C, Doutre MS.

Int J Dermatol. 2019 Jun;58(6):e112-e114. doi: 10.1111/ijd.14416. Epub 2019 Mar 18. No abstract available.

PMID:
30883695
18.

Cutaneous lymphomas appearing during treatment with biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database.

Dequidt L, Franck N, Sanchez-Pena P, Dalle S, Adamski H, Boulinguez S, Ingen-Housz-Oro S, Ram-Wolff C, Boccara O, Bonnet N, Cortes B, Gouraud A, Grange F, Le Corre Y, Quereux G, De Masson A, Schmutz JL, Skowron F, Verneuil L, Beylot-Barry M.

Br J Dermatol. 2019 Sep;181(3):616-618. doi: 10.1111/bjd.17834. Epub 2019 May 29. No abstract available.

PMID:
30835817
19.

Clinical presentation, therapeutic approach and outcome of primary cutaneous marginal zone B-cell lymphoma presenting as AL amyloidoma of the skin.

Dangien A, Beylot-Barry M, Battistella M, Ram-Wolff C, Talbot A, Rybojad M, Vergier B, Jachiet M, Bouaziz JD, Arnulf B, Bagot M, de Masson A.

Br J Dermatol. 2019 Sep;181(3):607-609. doi: 10.1111/bjd.17821. Epub 2019 May 13. No abstract available.

PMID:
30801660
20.

Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.

Menguy S, Beylot-Barry M, Parrens M, Ledard AP, Frison E, Comoz F, Battistella M, Szablewski V, Balme B, Croue A, Franck F, Ortonne N, Tournier E, Lamant L, Carlotti A, De Muret A, Le Gall F, Lorton MH, Merlio JP, Vergier B.

Histopathology. 2019 Jun;74(7):1067-1080. doi: 10.1111/his.13832. Epub 2019 Apr 25.

PMID:
30715765
21.

Adverse events need for hospitalization and systemic immunosuppression in very elderly patients (over 80 years) treated with ipilimumab for metastatic melanoma.

Leroy V, Gerard E, Dutriaux C, Prey S, Gey A, Mertens C, Beylot-Barry M, Pham-Ledard A.

Cancer Immunol Immunother. 2019 Apr;68(4):545-551. doi: 10.1007/s00262-019-02298-9. Epub 2019 Jan 19.

PMID:
30661086
22.

Three cases of bacterial osteomyelitis associated with hidradenitis suppurativa.

Blaizot R, Fernandez P, Cogrel O, Beylot-Barry M, Pham-Ledard A.

Br J Dermatol. 2019 Jun;180(6):1537-1538. doi: 10.1111/bjd.17593. Epub 2019 Feb 4. No abstract available.

PMID:
30588606
23.

Long-lasting cutaneous tuberculosis owing to Mycobacterium bovis masquerading as sarcoidosis.

Dequidt L, Dousset L, Pham-Ledard A, Doutre MS, Beylot-Barry M.

JAAD Case Rep. 2018 Nov 27;5(1):1-4. doi: 10.1016/j.jdcr.2018.07.020. eCollection 2019 Jan. No abstract available.

24.

Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.

Garel B, Ingen-Housz-Oro S, Afriat D, Prost-Squarcioni C, Tétart F, Bensaid B, Bara Passot C, Beylot-Barry M, Descamps V, Duvert-Lehembre S, Grootenboer-Mignot S, Jeudy G, Soria A, Valnet-Rabier MB, Barbaud A, Caux F, Lebrun-Vignes B.

Br J Clin Pharmacol. 2019 Mar;85(3):570-579. doi: 10.1111/bcp.13827. Epub 2019 Jan 4.

PMID:
30511379
25.

Dose-limiting stomatitis associated with ibrutinib therapy: a case series.

Vigarios E, Beylot-Barry M, Jegou MH, Oberic L, Ysebaert L, Sibaud V.

Br J Haematol. 2019 May;185(4):784-788. doi: 10.1111/bjh.15620. Epub 2018 Nov 8. No abstract available.

PMID:
30408164
26.

[Cutaneous lymphomas: breakthroughs and future prospects in 2018].

Beylot-Barry M.

Ann Dermatol Venereol. 2018 Dec;145(12S):S10-S11. doi: 10.1016/j.annder.2018.09.160. Epub 2018 Nov 1. French. No abstract available.

PMID:
30391032
27.

Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort.

Kandel M, Allayous C, Dalle S, Mortier L, Dalac S, Dutriaux C, Leccia MT, Guillot B, Saiag P, Lacour JP, Legoupil D, Lesimple T, Aubin F, Beylot-Barry M, Brunet-Possenti F, Arnault JP, Granel-Brocard F, Stoebner PE, Dupuy A, Maubec E, Grob JJ, Dreno B, Rotolo F, Ballon A, Michiels S, Lebbe C, Borget I.

Eur J Cancer. 2018 Dec;105:33-40. doi: 10.1016/j.ejca.2018.09.026. Epub 2018 Oct 29.

PMID:
30384014
28.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology.

J Invest Dermatol. 2019 Jan;139(1):31-37. doi: 10.1016/j.jid.2018.04.042. Epub 2018 Oct 6. Review.

PMID:
30301637
29.

Treatment of mycosis fungoides and Sézary syndrome with romidepsin: a series of 32 cases from the French Study Group for Cutaneous Lymphoma.

Deschamps O, Ram-Wolff C, Beylot-Barry M, Grange F, Skowron F, Dereure O, Boulinguez S, Aubin F, Ingen-Housz-Oro S, Bagot M; French Study Group for Cutaneous Lymphoma.

Br J Dermatol. 2019 Feb;180(2):423-424. doi: 10.1111/bjd.17269. Epub 2018 Nov 22. No abstract available.

PMID:
30298903
30.

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.

Scarisbrick JJ, Quaglino P, Prince HM, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz-Romero P, Stadler R, Patsatsi A, Knobler R, Guenova E, Child F, Whittaker S, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram-Wolff C, Battistella M, Alberti-Violetti S, Stranzenbach R, Gargallo V, Muniesa C, Koletsa T, Jonak C, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio A, Dummer R, Pimpinelli N, Grandi V, Beylot-Barry M, Pham-Ledard A, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Trautinger F, Latzka J, Yoo J, Vydianath B, Amel-Kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon-Pennamen MD, Battistella M, Climent F, Gonzalez-Barca E, Georgiou E, Senetta R, Zinzani P, Vakeva L, Ranki A, Busschots AM, Hauben E, Bervoets A, Woei-A-Jin FJSH, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, McKay P, Arumainathan A, Azurdia R, Benstead K, Twigger R, Rieger K, Brown R, Sanches JA, Miyashiro D, Akilov O, McCann S, Sahi H, Damasco FM, Querfeld C, Folkes A, Bur C, Klemke CD, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Willemze R.

Br J Dermatol. 2019 Aug;181(2):350-357. doi: 10.1111/bjd.17258. Epub 2018 Nov 25.

PMID:
30267549
31.

GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis.

Larsabal M, Ly S, Sbidian E, Moyal-Barracco M, Dauendorffer JN, Dupin N, Richard MA, Chosidow O, Beylot-Barry M.

Br J Dermatol. 2019 Mar;180(3):647-656. doi: 10.1111/bjd.17147. Epub 2018 Nov 1.

PMID:
30188572
32.

Infectious events and associated risk factors in mycosis fungoides/Sézary syndrome: a retrospective cohort study.

Blaizot R, Ouattara E, Fauconneau A, Beylot-Barry M, Pham-Ledard A.

Br J Dermatol. 2018 Dec;179(6):1322-1328. doi: 10.1111/bjd.17073. Epub 2018 Oct 12.

PMID:
30098016
33.

Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy.

Dupuis F, Lamant L, Gerard E, Torossian N, Chaltiel L, Filleron T, Beylot-Barry M, Dutriaux C, Prey S, Gros A, Jullie ML, Meyer N, Vergier B.

Br J Cancer. 2018 Jul;119(2):193-199. doi: 10.1038/s41416-018-0168-9. Epub 2018 Jul 5.

34.

Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015.

Polivka L, Oubaya N, Bachelez H, Paul C, Richard MA, Beylot-Barry M, Schmutz JL, Beneton N, Mahé E, Viguier M, Chosidow O, Canoui-Poitrine F, Sbidian E; Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie.

J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1920-1929. doi: 10.1111/jdv.15044. Epub 2018 May 31.

PMID:
29729123
35.

A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type.

Beylot-Barry M, Mermin D, Maillard A, Bouabdallah R, Bonnet N, Duval-Modeste AB, Mortier L, Ingen-Housz-Oro S, Ram-Wolff C, Barete S, Dalle S, Maubec E, Quereux G, Templier I, Bagot M, Grange F, Joly P, Vergier B, Vially PJ, Gros A, Pham-Ledard A, Frison E, Merlio JP.

J Invest Dermatol. 2018 Sep;138(9):1982-1989. doi: 10.1016/j.jid.2018.03.1516. Epub 2018 Mar 27.

36.

Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas.

Menguy S, Frison E, Prochazkova-Carlotti M, Dalle S, Dereure O, Boulinguez S, Dalac S, Machet L, Ram-Wolff C, Verneuil L, Gros A, Vergier B, Beylot-Barry M, Merlio JP, Pham-Ledard A.

Mod Pathol. 2018 Aug;31(8):1332-1342. doi: 10.1038/s41379-018-0041-7. Epub 2018 Mar 26.

37.

Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study.

Richard MA, Corgibet F, Beylot-Barry M, Barbaud A, Bodemer C, Chaussade V, D'Incan M, Joly P, Leccia MT, Meurant JM, Petit A, Geffroy BR, Sei JF, Taieb C, Misery L, Ezzedine K.

J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1967-1971. doi: 10.1111/jdv.14959. Epub 2018 Jul 16.

PMID:
29569785
38.

[Guide to university hospital careers in dermatology. The GRENT (Graines Engrais Tuteurs - Seed Fertilizer Plant stick) Program].

Gaudy-Marqueste C, Samimi M, Soria A, Aractingi S, Bodemer C, Chosidow O, Cribier B, Lacour JP, Paul C, Richard MA, Beylot-Barry M, Dreno B.

Ann Dermatol Venereol. 2018 Mar;145(3):200-209. doi: 10.1016/j.annder.2017.11.010. Epub 2018 Feb 12. French. No abstract available.

PMID:
29449018
39.

T-cell papulosis associated with B-cell malignancy: a distinctive clinicopathologic entity.

Visseaux L, Durlach A, Barete S, Beylot-Barry M, Bonnet N, Chassine A, Franck N, Herve G, Leclec'h C, Machet L, Ingen-Housz-Oro S, Petrella T, Vergier B, Ortonne N, Grange F.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1469-1475. doi: 10.1111/jdv.14805. Epub 2018 Feb 12.

PMID:
29356170
40.

[On the attractiveness of a university-hospital career in medicine: Obstacles and solutions. The teachers' perspective].

Samimi M, Dreno B, Aractingi S, Beylot-Barry M, Bodemer C, Chosidow O, Cribier B, Lacour JP, Paul C, Richard MA, Gaudy-Marqueste C, Soria A; le Conseil National des universitaires de dermato-vénéréologie, sous-section 50.03.

Ann Dermatol Venereol. 2018 Mar;145(3):196-199. doi: 10.1016/j.annder.2017.10.014. Epub 2017 Dec 11. French. No abstract available.

PMID:
29241631
41.

[Attractiveness of a university hospital career in France: Analysis of perceptions among young dermatologists in 2016].

Soria A, Dreno B, Aractingi S, Beylot-Barry M, Bodemer C, Chosidow O, Cribier B, Lacour JP, Paul C, Richard MA, Gaudy-Marqueste C, Samimi M; les membres du Collège National des universités de dermato-vénéréologie, sous-section 50.03.

Ann Dermatol Venereol. 2018 Mar;145(3):191-196. doi: 10.1016/j.annder.2017.11.003. Epub 2017 Dec 6. French. No abstract available.

PMID:
29223610
42.

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.

Kostine M, Rouxel L, Barnetche T, Veillon R, Martin F, Dutriaux C, Dousset L, Pham-Ledard A, Prey S, Beylot-Barry M, Daste A, Gross-Goupil M, Lallier J, Ravaud A, Forcade E, Bannwarth B, Truchetet ME, Richez C, Mehsen N, Schaeverbeke T; FHU ACRONIM.

Ann Rheum Dis. 2018 Mar;77(3):393-398. doi: 10.1136/annrheumdis-2017-212257. Epub 2017 Nov 16.

PMID:
29146737
43.

PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.

Menguy S, Prochazkova-Carlotti M, Beylot-Barry M, Saltel F, Vergier B, Merlio JP, Pham-Ledard A.

Am J Surg Pathol. 2018 Mar;42(3):326-334. doi: 10.1097/PAS.0000000000000983.

PMID:
29112015
44.

Treatment of prurigo with methotrexate: a multicentre retrospective study of 39 cases.

Klejtman T, Beylot-Barry M, Joly P, Richard MA, Debarbieux S, Misery L, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S.

J Eur Acad Dermatol Venereol. 2018 Mar;32(3):437-440. doi: 10.1111/jdv.14646. Epub 2017 Nov 7.

PMID:
29055135
45.

Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas.

Leclaire Alirkilicarslan A, Dupuy A, Pujals A, Parrens M, Vergier B, Robson A, Delfau-Larue MH, Ingen-Housz-Oro S, Chosidow O, Haioun C, Beylot-Barry M, Merlio JP, Copie-Bergman C, Gaulard P, Ortonne N.

Am J Surg Pathol. 2017 Dec;41(12):1581-1592. doi: 10.1097/PAS.0000000000000956.

PMID:
28945625
46.

Molecular analysis of immunoglobulin variable genes supports a germinal center experienced normal counterpart in primary cutaneous diffuse large B-cell lymphoma, leg-type.

Pham-Ledard A, Prochazkova-Carlotti M, Deveza M, Laforet MP, Beylot-Barry M, Vergier B, Parrens M, Feuillard J, Merlio JP, Gachard N.

J Dermatol Sci. 2017 Nov;88(2):238-246. doi: 10.1016/j.jdermsci.2017.07.008. Epub 2017 Jul 26.

PMID:
28838616
47.

« Malignant » Rosacea as a sign of systemic marginal zone lymphoma.

Lamoureux A, Vergier B, Fidelin-Ferrati G, Hans P, Milpied N, Beylot-Barry M.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e71-e72. doi: 10.1111/jdv.14502. Epub 2017 Aug 22. No abstract available.

PMID:
28776782
48.

Agreement Between Self-reported Inflammatory Skin Disorders and Dermatologists' Diagnosis: A Cross-sectional Diagnostic Study.

Phan C, Ezzedine K, Lai C, Le Cleach L, Cogrel O, Fardet L, Wolkenstein P, Chosidow O, Beylot-Barry M, Sbidian E.

Acta Derm Venereol. 2017 Nov 15;97(10):1243-1244. doi: 10.2340/00015555-2749. No abstract available.

49.

[Treatment of Hailey-Hailey disease with botulinic toxin: A retrospective study of 8 cases].

Dousset L, Pham-Ledard A, Doutre MS, Beylot-Barry M, Cogrel O.

Ann Dermatol Venereol. 2017 Oct;144(10):599-606. doi: 10.1016/j.annder.2017.05.014. Epub 2017 Jun 29. French.

PMID:
28669425
50.

Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort.

Sbidian E, Giboin C, Bachelez H, Paul C, Beylot-Barry M, Dupuy A, Viguier M, Lacour JP, Schmutz JL, Bravard P, Mahé E, Beneton N, Misery L, Delaporte E, Modiano P, Barbarot S, Regnier E, Jullien D, Richard MA, Joly P, Tubach F, Chosidow O.

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2046-2054. doi: 10.1111/jdv.14406. Epub 2017 Jul 16.

Supplemental Content

Loading ...
Support Center